Effects of chronic monoamine oxidase inhibitor treatment on biogenic amine metabolism in rat brain.
D000818:Animals; D001142:Aromatic-L-Amino-Acid Decarboxylases / Q000378:metabolism; D001679:Biogenic Amines / Q000378:metabolism*; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D004298:Dopamine / Q000378:metabolism; D008297:Male; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D009638:Norepinephrine / Q000378:metabolism; D010624:Phenelzine / Q000494:pharmacology; D051381:Rats; D014191:Tranylcypromine / Q000494:pharmacology; D014365:Tryptophan Hydroxylase / Q000378:metabolism; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism
D001679:Biogenic Amines; D008996:Monoamine Oxidase Inhibitors; D014191:Tranylcypromine; D014446:Tyrosine 3-Monooxygenase; D014365:Tryptophan Hydroxylase; D001142:Aromatic-L-Amino-Acid Decarboxylases; D010624:Phenelzine; D004298:Dopamine; D009638:Norepinephrine